<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03348839</url>
  </required_header>
  <id_info>
    <org_study_id>PRME-16-0418</org_study_id>
    <nct_id>NCT03348839</nct_id>
  </id_info>
  <brief_title>Medico-economic Impacts of NeLLY Service for Not on Dialysis Severe Chronic Kidney Disease</brief_title>
  <official_title>Multicentre Trial, With Stepped Wedge Randomized Controled Clusters, on Medico-economic Impacts of NeLLY Service for Not on Dialysis Severe Chronic Kidney Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Calydial</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Calydial</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This medico-economic research project (PRME) aim to analyse NeLLY service efficiency for not
      on dialysis severe chronic kidney disease (DFG &lt; 30ml/mn) patients care. NeLLY is a service
      that includes telemonitoring, educational therapy and support for patients with severe
      chronic kidney disease.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      NeLLY study is a multicentre trial, with stepped wedge randomized controled clusters. 2
      strategies will be compared: usual patients follow-up and NeLLY service. The primary endpoint
      of the study is incremental cost-effectiveness ratio. This 3 years study will include 600
      French patients.

      NeLLY service, offering telemonitoring, educational therapy and support to patients with
      severe chronic kidney disease, is based on an app, both for patients and health
      professionals, named Ap'Telecare (@TMM).
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 2018</start_date>
  <completion_date type="Anticipated">June 2021</completion_date>
  <primary_completion_date type="Anticipated">June 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Multicentre study, in randomized mastered clusters, in stepped wedge</intervention_model_description>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>no one</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Incremental cost-effectiveness ratio</measure>
    <time_frame>Data collection all along the study: 3 years</time_frame>
    <description>The primary endpoint of the study is incremental cost-effectiveness ratio comparing 2 strategies : usual patients follow-up and NeLLY service</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluation of costs related to each strategy</measure>
    <time_frame>Data collection every 4 months at least, all along the study: 3 years</time_frame>
    <description>All medical expenses will be collected in the case report form</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of quality of life related to each strategy</measure>
    <time_frame>every 4 months, all along the study: 3 years</time_frame>
    <description>Specific questionnaire analysing patient's mobility, autonomy, pain and discomfort, anxiety and depression (patient's answer can be yes or no)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of the financial impact of NeLLY service implementation in France</measure>
    <time_frame>Data collection every 4 months at least, all along the study: 3 years</time_frame>
    <description>All medical expenses will be collected in the case report form</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of clinical impact of NeLLY service</measure>
    <time_frame>Data collection all along the study: 3 years</time_frame>
    <description>The question is: does NeLLY reduce hospitalisation, slow chronic kidney disease evolution, increase blood pressure control. Data will be collected during usual nephrology consultations.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of NeLLY service impacts on dialysis and transplant</measure>
    <time_frame>Data collection all along the study: 3 years</time_frame>
    <description>The question is: does NeLLY delay resorting to dialysis, avoid emergency dialysis, encourage transplant</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of NeLLY service impacts on compliance of patients</measure>
    <time_frame>4 times during the study: 3 years</time_frame>
    <description>Specific questionnaire:
Did the patient forget this morning to take medication? Since his last consultation, did the patient already miss any medication at home? Is the patient sometimes late to take medication? Did the patient already forget medication because of a lapse of memory? Did the patient already miss to take a medication because the patient think it can do more harm than good? Do the patient believe having too many medication to take? Patient's answer can be yes or no.</description>
  </secondary_outcome>
  <number_of_arms>7</number_of_arms>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Chronic Kidney Disease stage4</condition>
  <condition>Kidney Diseases</condition>
  <arm_group>
    <arm_group_label>Cluster 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>NeLLY service is implemented after 8 months.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cluster 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>NeLLY service is implemented after 12 months.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cluster 3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>NeLLY service is implemented after 16 months.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cluster 4</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>NeLLY service is implemented after 20 months.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cluster 5</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>NeLLY service is implemented after 24 months.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cluster 6</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>NeLLY service is implemented after 28 months.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cluster 7</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>NeLLY service is implemented after 32 months.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>NeLLY service</intervention_name>
    <description>Telesurveillance and therapeutic support</description>
    <arm_group_label>Cluster 1</arm_group_label>
    <arm_group_label>Cluster 2</arm_group_label>
    <arm_group_label>Cluster 3</arm_group_label>
    <arm_group_label>Cluster 4</arm_group_label>
    <arm_group_label>Cluster 5</arm_group_label>
    <arm_group_label>Cluster 6</arm_group_label>
    <arm_group_label>Cluster 7</arm_group_label>
    <other_name>Ap'Telecare</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patient with chronic kidney disease stage 4

          -  patient with at least 1 cardiovascular comorbidity and / or diabetes

          -  patient with internet connexion from home

          -  patient having given his express consent

        Exclusion Criteria:

          -  dialysed patient

          -  refusal of patient to take part in the research

          -  impairment of vital prognosis within a short period

          -  patient expecting a transplant from a living donor within 6 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>CAILLETTE BEAUDOIN Agnès</last_name>
    <role>Principal Investigator</role>
    <affiliation>Calydial</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>CAILLETTE BEAUDOIN Agnès</last_name>
    <phone>428873800</phone>
    <phone_ext>+33</phone_ext>
    <email>direction@calydial.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>CAMARROQUE Anne-Laure</last_name>
    <phone>428873851</phone>
    <phone_ext>+33</phone_ext>
    <email>anne-laure.camarroque@calydial.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU Caen</name>
      <address>
        <city>Caen</city>
        <zip>14033</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>LOBBEDEZ Thierry</last_name>
      <phone>231272343</phone>
      <phone_ext>+33</phone_ext>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Chalon</name>
      <address>
        <city>Chalon-sur-Saône</city>
        <zip>71100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>DUBOT Philippe</last_name>
      <phone>3 85 91 00 56</phone>
      <phone_ext>+33</phone_ext>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Clermont Ferrand</name>
      <address>
        <city>Clermont-Ferrand</city>
        <zip>63000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>HENG Anne-Elisabeth</last_name>
      <phone>473751425</phone>
      <phone_ext>+33</phone_ext>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre hospitalier Saint Joseph Saint Luc</name>
      <address>
        <city>Lyon</city>
        <zip>60365</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>VILLAR Emmanuel</last_name>
      <phone>4 78 61 89 72</phone>
      <phone_ext>+33</phone_ext>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Marseille</name>
      <address>
        <city>Marseille</city>
        <zip>13005</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>BRUNET Philippe</last_name>
      <phone>4 91 38 30 42</phone>
      <phone_ext>+33</phone_ext>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Reims</name>
      <address>
        <city>Reims</city>
        <zip>51092</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>RIEU Philippe</last_name>
      <phone>3 26 78 76 38</phone>
      <phone_ext>+33</phone_ext>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Rennes</name>
      <address>
        <city>Rennes</city>
        <zip>35033</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>VIGNEAU Cécile</last_name>
      <phone>2 99 28 94 90</phone>
      <phone_ext>+33</phone_ext>
    </contact>
  </location>
  <location>
    <facility>
      <name>ARTIC 42</name>
      <address>
        <city>Saint-Étienne</city>
        <zip>42270</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>BERTHOUX François</last_name>
      <phone>4 77 91 03 86</phone>
      <phone_ext>+33</phone_ext>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Saint Etienne</name>
      <address>
        <city>Saint-Étienne</city>
        <zip>42270</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>ALAMARTINE Eric</last_name>
      <phone>4 77 82 83 45</phone>
      <phone_ext>+33</phone_ext>
    </contact>
  </location>
  <location>
    <facility>
      <name>CALYDIAL</name>
      <address>
        <city>Vienne</city>
        <zip>38200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>CAILLETTE BEAUDOIN Agnès</last_name>
      <phone>428873800</phone>
      <phone_ext>+33</phone_ext>
      <email>direction@calydial.org</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 14, 2017</study_first_submitted>
  <study_first_submitted_qc>November 16, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 21, 2017</study_first_posted>
  <last_update_submitted>January 16, 2018</last_update_submitted>
  <last_update_submitted_qc>January 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 18, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>telemedicine</keyword>
  <keyword>telemonitoring</keyword>
  <keyword>educational therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

